|
| |
| |
Stille's press releases and non-published news are primarily available in Swedish. To view our press releases and news in Swedish, please use the link below. Below are selected news highlights in English. |
| |
2012.02.15
Stille reports full year 2011 financials
Sales in 2011 grew with 8% to 90 million SEK. Adjusted for currency effects, sales grew with 13%. Stille reports a turn around with positive EBIT before one-time costs, as compared to last year's loss of -2,6 million SEK. The Q4 results were affected by one-time costs as a function of the new revised Stille strategy. For more details, please see the 2011 report available in Swedish. For Investor Relations related questions, please contact CEO Philip Siberg.
Please see the press release in Swedish here >> |
|
2012.01.18
Stille announces CFO succession
Effective February 1st, 2012, Carin Jakobsson will succeed Annette Colin as the CFO of Stille AB. Mrs. Jakobsson joined Stille in 2012 as Business Controller following various financial roles in companies as Flextronics and Relacom.
"Annette Colin has done a fantastic job for Stille with exceptional commitment and execution. We now have state of the art financial processes and control functions in place. Carin will now take over according to plans and I would like to wish Annette continued success in her future career.", comments Philip Siberg, CEO of Stille.
Please see the press release in Swedish here >>
|
|
2011.12.28
Stille signs partnership agreement with United Drug
Stille is proud to have signed an exclusive distribution agreement with United Drug PLC (LSE:UDG), a leading multinational healthcare services provider, employing over 4,100 people across Europe and the US. United Drug operates through three divisions with over 1,7 billion Euro in sales.
In 2003, United Drug acquired the UK based orthopedic company Newsplint PLC, with a history of successfully selling Stille’s instruments on the UK market in the 1990’s.
Effective January 1st, 2012, United Drug Medical Trading as Newsplint, will assume the status as the exclusive distributor of Stille’s surgical instruments on the UK market.
For any enquiries, please contact Mr. Doug Low, General Manager, Newsplint, on doug.low@udmedical.com or Mr. Niclas Swanér, VP Sales Stille AB, niclas.swaner@stille.se
|
2011.12.27
Introducing the new "Stille 2012 Perfection Commitment"
Stille’s surgical instruments are considered the finest in the world. As a continued tribute to clinicans and patients, we are proud to launch our new 2012 Perfection Commitment. The new Stille promise stipulates market leading 30 year warranty, free Genuine Stille Service and a 48 hour shipment commitment on the best selling products.
Our passion for perfection and precision is clear, a commitment to surgeons and patients throughout the world. See leaflet for an introduction and please do not hesitate to contact us for more information
Stille 2012 Perfection Commitment as PDF
|
2011.12.27
Launch of Stille Innovation
The Stille Innovation program is a new initiative offered by Stille to enable efficient realization and commercialization of surgical instrument ideas.
Stille has over 170 years of experience in developing surgical tools in collaboration with leading clinicians. All instruments are handcrafted as an art in Eskilstuna, Sweden. The instrument makers master the forging of Stille’s specialized surgical steel, thus the creation of nearly any type of custom made product. Instruments are sold through a direct sales force and distributors covering more than 50 countries in the world.
Who is better to help design, produce, approve and commercialize your new ideas?
Please see the pamphlet for more info. More info to follow shortly.
Stille Innovation as PDF
|
2011.11.18
Nomination Committee in Stille AB before Annual General Meeting 2012
In accordance with the resolution of Stille AB's (publ) Annual General Meeting April 13, 2011, the members of the Nomination Committee before the AGM 2012 be appointed by the Chairman contacting the three largest shareholders in the company and ask them to appoint one representative each of together with the Chairman of the Board. The Nominating Committee then appoints a chairman. The three largest owners were, at September 30, 2011, Linc Invest AB, Garden Growth Capital LLC and Philip Siberg.
Nomination Committee for Annual General Meeting 2012
will consist of the following persons:
Bengt Julander, Linc Invest
Bruce Grant, Garden Growth Capital LLC
Philip Siberg
Ulf Rosén, Chairman Stille AB |
|
2011.11.16
Stille reports Q3 2011 financials
Sales in January-Sept grew with 15% to 66,4 MSEK. Adjusted for currency effects, sales grew with 22%. Stille reports a turn around with positive earnings and cash flow generation for the first 9 months of the year, as compared to last year's loss of -3,5 million SEK. For more details, please see the Q3 report available in Swedish. For Investor Relations related questions, please contact CEO Philip Siberg or CFO Annette Colin. |
|
2011.10.05
Stille partners with Lawton GmbH
Stille is proud to have signed a distribution partnership agreement with Lawton GmbH. Lawton is a leading German supplier of high quality instruments for various applications. The instruments will only be available on the Swedish market. For more info, please contact Mr. Pontus Lüning.
|
|
2011.09.08
Introducing Tontarra - solutions for spinal and neuro surgery
We are proud to present our new partnership with Tontarra, a leading German manufacturer of high quality instruments for mainly spinal and neuro surgery. The instruments are only available through Stille on the Swedish market. For more information, please contact Mr. Pontus Lüning.
|
|
2011.08.24
Stille reports Q2 2011 financials
Sales in January-June grew with 25,4% to 46,6 MSEK. Adjusted for currency effects, sales grew with 33%. Stille reports positive earnings and cash flow generation. For more details, please see the Q2 report available in Swedish. For Investor Relations related questions, please contact CEO Philip Siberg or CFO Annette Colin.
|
|
2011.05.23
Philip Siberg acquires 7,2% of Stille
Stille’s new CEO has acquired 7,2% of the shares of Stille. For more info, please contact CEO Philip Siberg or CFO Annette Colin. |
|
2011.05.23
Philip Siberg appointed new President & CEO of Stille
Philip Siberg joins Stille on August 8th, 2011. For a bio, please see link |
|
2011.05.18
Stille reports Q1 2011 financials
Stille reports growth and positive earnings. Sales in Q1 2011 grew with 27,2% to reach 24,0 MSEK. Adjusted for currency effects, the growth was 31,2%. Stille reported positve net earnings. For more details, please see the Q1 report available in Swedish. For Investor Relations related questions, please contact CEO Philip Siberg or CFO Annette Colin.
|
|
2011.04.14
Ulf Rosén new Chairman of the Board
Ulf Rosén appointed new Chairman of the Baord of Stille AB. Mr. Rosén was elected Board Member in 2010 and is a trained nurse, and graduate from the IHM Business School. CEO of Life Science Management Group/RTC AB. Chairman of the board of Trial Form Support AB. Member of the boards of SciBase Holding AB, Abilia Holding AB, Globen Ögonklinik AB and ProstaLund AB. |
|
2011.03.31
Stille Annual report 2011
The Annual report of 2010 is now available online, unfortunately only in Swedish. For Investor Relations related questions, please contact CEO Philip Siberg or CFO Annette Colin
|
|
2011.02.07
Jacob Rasin to leave as CEO of Stille AB
Jacob Rasin announced today his intent to leave Stille AB and join Egon Zehnder International. The recruitment of a new CEO has been initiated. |
|
|
|
| |
|
|
|
|
